The Medical University of South Carolina (MUSC) in the US and Revival Healthcare Capital have entered a five-year partnership aimed at advancing the clinical development of medical technologies.
The agreement outlines plans for both organisations to collaborate on the assessment and progression of next-generation medical devices, with MUSC providing clinical expertise and procedural feedback relevant to Revival’s investment focus.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The collaboration also established a scalable model to support the swift launch of project-specific initiatives.
MUSC experts may advise Revival’s portfolio companies, contributing clinical validation and insights to support various stages of product development.
The collaboration will also allow Revival to evaluate medical device development originating from MUSC, potentially facilitating additional clinical advancement through Revival’s network and resources.
The university stated that its approach is centred on converting scientific and clinical findings into applicable solutions, and that the partnership with Revival will help direct investment and operational resources to support this mission.
MUSC president David Cole said: “This collaboration reflects MUSC’s commitment to advancing innovation that improves patient care and health outcomes.
“By working closely with Revival Healthcare Capital, our clinicians and researchers can help evaluate and inform the development of promising medical technologies, strengthening the pathway from clinical insight to real-world impact.”
Revival provides investment to medical device companies and aims to form partnerships that enable the advancement of new technologies.
Revival Healthcare Capital senior partner Todd Pope said: “We are pleased to partner with MUSC to create a repeatable, high-velocity collaboration model that supports our investment strategy and our portfolio companies.
“By combining Revival’s flexible capital model and operational capabilities with MUSC’s strong collaboration across patient care, research and education, we believe this partnership can advance technologies that address unmet patient needs.”
